Conditions: Pancreatic Ductal Adenocarcinoma (PDAC); Cancer of Pancreas; Pancreatic Cancer, Adult; Pancreas Adenocarcinoma; Pancreatic Neoplasms; Pancreatic Cancer Non-resectable; Pancreatic Cancer Resectable
Interventions: Drug: Oxaliplatin; Drug: Leucovorin; Drug: Irinotecan Hydrochloride; Drug: 5-FU
Sponsor: UNC Lineberger Comprehensive Cancer Center
Not yet recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
June 7, 2019ClinicalTrials.govComments OffHepatology(Liver, Pancreatic, Gall Bladder)Cancer | FOLFIRINOX | Nonmetastatic | Pancreatic | Subjects | Subtypes | Tumor
Comments



